tiprankstipranks
Trending News
More News >
Fmc Corp. (FMC)
NYSE:FMC
Advertisement

FMC (FMC) AI Stock Analysis

Compare
1,547 Followers

Top Page

FMC

FMC

(NYSE:FMC)

Select Model
Select Model
Select Model
Neutral 48 (OpenAI - 4o)
Rating:48Neutral
Price Target:
$13.50
▼(-3.50% Downside)
FMC's overall stock score reflects significant financial and operational challenges. The most impactful factors include declining revenues, profitability issues, and cash flow constraints. Technical analysis indicates bearish momentum, and while the high dividend yield is attractive, the recent cut raises sustainability concerns. The earnings call provided mixed signals, with strategic adjustments needed to address ongoing challenges.
Positive Factors
Strong Growth in EMEA Region
The strong growth in the EMEA region indicates a robust market position and effective product strategy, contributing to long-term revenue stability and expansion opportunities.
Promising Outlook for New Products
The introduction of new active ingredients like fluindapyr and Isoflex supports future growth, enhancing FMC's competitive edge and product portfolio diversification.
Successful Debt Management
Effective debt management improves financial stability and flexibility, allowing FMC to better navigate market fluctuations and invest in growth initiatives.
Negative Factors
Challenges in India Market
The divestment in India reflects significant operational challenges, potentially limiting FMC's market reach and revenue diversification in a key region.
Pricing Pressures
Ongoing pricing pressures could erode profit margins, impacting FMC's ability to sustain profitability and invest in future growth.
North America Sales Decline
Declining sales in North America highlight demand volatility and potential market saturation, posing risks to FMC's revenue consistency and growth prospects.

FMC (FMC) vs. SPDR S&P 500 ETF (SPY)

FMC Business Overview & Revenue Model

Company DescriptionFMC Corporation, an agricultural sciences company, provides crop protection, plant health, and professional pest and turf management products. It develops, markets, and sells crop protection chemicals that include insecticides, herbicides, and fungicides; and biologicals, crop nutrition, and seed treatment products, which are used in agriculture to enhance crop yield and quality by controlling a range of insects, weeds, and diseases, as well as in non-agricultural markets for pest control. The company markets its products through its own sales organization and through alliance partners, independent distributors, and sales representatives. It operates in North America, Latin America, Europe, the Middle East, Africa, and Asia. FMC Corporation was founded in 1883 and is headquartered in Philadelphia, Pennsylvania.
How the Company Makes MoneyFMC generates revenue through the sale of its crop protection products and solutions. The company's primary revenue streams include the sale of insecticides, herbicides, and fungicides, which are essential for protecting crops from pests and diseases. Additionally, FMC offers specialty products that enhance crop yield and quality, further contributing to its earnings. The company benefits from significant partnerships with agricultural distributors and retailers, allowing it to reach a broad customer base in various markets. Furthermore, FMC invests in research and development to innovate and expand its product portfolio, which helps to drive sales and maintain competitiveness in the agricultural industry.

FMC Key Performance Indicators (KPIs)

Any
Any
Revenue by Geography
Revenue by Geography
Breaks down revenue across different regions, revealing where the company is strongest and where it may face risk or growth potential due to local economic conditions or market share shifts.
Chart InsightsFMC's revenue trends reveal strong growth in EMEA and Latin America, supported by higher herbicide sales and a successful growing season. However, North America and Asia face declines, exacerbated by destocking and competitive pressures in India, prompting a strategic divestment. Despite these regional challenges, FMC's focus on cost efficiencies and new product launches is expected to drive future growth, with a projected 14% increase in adjusted EBITDA for Q3 2025. Investors should watch for the impact of pricing pressures and FX headwinds on overall performance.
Data provided by:Main Street Data

FMC Earnings Call Summary

Earnings Call Date:Oct 29, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 10, 2026
Earnings Call Sentiment Neutral
The earnings call presented both positive outcomes such as strong demand for new active ingredients and EBITDA improvement, alongside significant challenges including a sharp revenue decline, particularly in Latin America, and a substantial dividend cut to manage cash flow issues.
Q3-2025 Updates
Positive Updates
Strong Demand for New Active Ingredients
Sales of new active ingredients nearly doubled compared to the prior year, demonstrating strong demand for technological innovations.
Adjusted EBITDA Improvement
Reported adjusted EBITDA of $236 million, 17% higher than prior year, driven by disciplined cost control and a favorable product mix.
Positive North America and EMEA Performance
Sales in North America and EMEA improved due to higher volumes and the launch of Isoflex active in Great Britain.
Negative Updates
Significant Revenue Decline
Reported third quarter GAAP net sales of $542 million, which is 49% lower than the prior year, majorly due to onetime actions in India.
Challenges in Latin America
Sales in Latin America lagged prior year by 8% due to constrained credit in Brazil and Argentina and pricing pressure from generics.
Free Cash Flow Challenges
Lowered free cash flow guidance to a range of negative $200 million to $0, impacted by collection delays and reduced liquidity.
Dividend Reduction
Board of Directors reduced the quarterly dividend by over 85% to $0.08 per share to redirect cash flow towards debt reduction.
Company Guidance
During the Third Quarter 2025 Earnings Call, FMC Corporation provided guidance reflecting challenging market conditions and strategic adjustments. The company reported adjusted EBITDA of $236 million with an EBITDA margin of approximately 25%, which was 17% higher on an as-reported basis and 23% higher on a like-for-like basis, excluding India. Adjusted earnings per share were $0.89, up 30% from the prior year. However, FMC lowered its full-year guidance, expecting revenue between $3.92 billion and $4.02 billion, with adjusted EBITDA between $830 million and $870 million. Free cash flow guidance was revised to a range of negative $200 million to $0. For the fourth quarter, the company anticipates sales, excluding India, to be between $1.12 billion and $1.22 billion, with adjusted EBITDA expected to be between $265 million and $305 million. These updates reflect ongoing pricing pressures, particularly from generics, and strategic cost actions to enhance competitiveness.

FMC Financial Statement Overview

Summary
FMC's financial performance is mixed. Strong revenue growth and operational efficiency are offset by declining net income and cash flow issues. The balance sheet is stable, but increasing leverage and reduced return on equity are concerns.
Income Statement
45
Neutral
FMC's income statement shows a mixed performance. The TTM (Trailing-Twelve-Months) gross profit margin is healthy at 39.55%, but the net profit margin has declined significantly to 2.40% from 29.39% in 2023. Revenue growth has been volatile, with a recent increase of 29.4% in the TTM after a decline in previous periods. The EBIT and EBITDA margins are stable, indicating operational efficiency, but the sharp drop in net income is a concern.
Balance Sheet
60
Neutral
The balance sheet reflects a stable financial position with a debt-to-equity ratio of 0.94 in the TTM, which is manageable. However, this is an increase from previous years, indicating rising leverage. The return on equity has decreased to 2.22% in the TTM, down from 29.90% in 2023, suggesting reduced profitability. The equity ratio remains strong, indicating a solid capital structure.
Cash Flow
50
Neutral
FMC's cash flow statement shows challenges, with a negative free cash flow in the TTM and a significant decline in free cash flow growth. The operating cash flow to net income ratio is low at 0.017, indicating cash flow issues. The free cash flow to net income ratio is negative, highlighting potential liquidity concerns.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.56B4.25B4.49B5.80B5.05B4.64B
Gross Profit1.31B1.58B1.91B2.39B2.19B2.07B
EBITDA208.40M737.40M786.20M1.30B1.19B1.04B
Net Income-534.90M339.90M1.32B736.50M739.60M552.40M
Balance Sheet
Total Assets12.08B11.65B11.93B11.17B10.58B10.19B
Cash, Cash Equivalents and Short-Term Investments497.70M357.30M302.40M572.00M516.80M568.90M
Total Debt1.27B3.50B4.11B3.27B3.17B3.27B
Total Liabilities8.28B7.14B7.49B7.77B7.53B7.20B
Stockholders Equity3.77B4.49B4.41B3.40B3.05B2.98B
Cash Flow
Free Cash Flow-285.40M603.20M-520.30M440.10M720.00M580.60M
Operating Cash Flow-263.80M671.10M-386.40M582.40M820.10M647.80M
Investing Cash Flow375.80M263.60M-154.40M-266.40M-112.00M-169.30M
Financing Cash Flow-483.00M-870.10M331.50M-237.40M-747.90M-250.30M

FMC Technical Analysis

Technical Analysis Sentiment
Negative
Last Price13.99
Price Trends
50DMA
30.96
Negative
100DMA
35.45
Negative
200DMA
37.35
Negative
Market Momentum
MACD
-5.02
Positive
RSI
9.84
Positive
STOCH
0.17
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FMC, the sentiment is Negative. The current price of 13.99 is below the 20-day moving average (MA) of 25.16, below the 50-day MA of 30.96, and below the 200-day MA of 37.35, indicating a bearish trend. The MACD of -5.02 indicates Positive momentum. The RSI at 9.84 is Positive, neither overbought nor oversold. The STOCH value of 0.17 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FMC.

FMC Risk Analysis

FMC disclosed 37 risk factors in its most recent earnings report. FMC reported the most risks in the "Macro & Political" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

FMC Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$13.78B10.2527.46%2.45%12.59%31.40%
65
Neutral
$8.32B6.8010.00%3.40%3.82%239.39%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
55
Neutral
$8.51B23.176.24%3.24%-1.22%-14.31%
50
Neutral
$3.23B22.654.71%-3.93%
48
Neutral
$1.68B-11.52%17.89%-13.42%-136.59%
28
Underperform
$342.34M-0.1842.75%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FMC
FMC
12.97
-43.43
-77.00%
CF
Cf Industries Holdings
82.03
0.28
0.34%
MOS
Mosaic Co
24.92
-1.99
-7.40%
SMG
Scotts Miracle-Gro Company
56.49
-13.20
-18.94%
ICL
Icl
5.64
1.63
40.65%
USBC
USBC
0.83
-9.17
-91.70%

FMC Corporate Events

FMC Corp’s Earnings Call: Mixed Sentiments and Strategic Shifts
Nov 1, 2025

FMC Corp’s recent earnings call painted a mixed picture, highlighting both positive developments and significant challenges. The sentiment was balanced, with optimism stemming from strong demand for new active ingredients and improved EBITDA, contrasted by concerns over a sharp revenue decline, particularly in Latin America, and a substantial dividend cut to address cash flow issues.

Understanding FMC Corp’s Risk Factors: Key Insights from Recent SEC Filings
Oct 31, 2025

FMC Corp faces potential business risks as outlined in their Form 10-Q and Form 10-K filings, which stakeholders should review carefully. These documents, accessible via the SEC and the company’s website, detail various risk factors that could impact FMC Corp’s operations and financial performance. Investors and analysts are advised to consider these risks in conjunction with other market conditions when evaluating the company’s future prospects. The comprehensive risk assessments provided in these reports are crucial for understanding the challenges FMC Corp may encounter in the coming months.

FMC Corporation Reports Q3 2025 Financial Results
Oct 31, 2025

FMC Corporation is a global agricultural sciences company focused on providing innovative crop protection solutions, including biologicals, crop nutrition, and digital agriculture, to help growers address challenges while protecting the environment.

Executive/Board Changes
FMC Announces President Ronaldo Pereira’s Departure
Neutral
Oct 29, 2025

On October 29, 2025, FMC Corporation announced that Ronaldo Pereira will step down as President effective December 15, 2025, after 28 years with the company. Pereira, a veteran in the crop protection industry, has significantly impacted FMC’s operations in Latin America and North America. He will remain in an advisory role until his departure to ensure a smooth transition.

The most recent analyst rating on (FMC) stock is a Buy with a $43.00 price target. To see the full list of analyst forecasts on FMC stock, see the FMC Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 05, 2025